You have read all your free articles, to continue reading subscribe to read the rest of this content.
Zelluna Immunotherapy has announced the appointment of Namir Hassan as its chief executive officer (CEO). “At this stage of Zelluna’s evolution, we are delighted to appoint Namir Hassan as CEO. Namir has made an invaluable contribution to Zelluna since he joined the company in 2018 as chief sAlready a subscriber…
Patrick Greatrex has been appointed the new CEO of Medtech company Vivo Line Medical, taking office March 9. He succeeds Peter Sebelius. Previously Greatrex was CEO of CMC Contrast, CEO of Combigene and vice president of Glycorex Transplantation. He also worked on business development for Gambro.Already a subscriber Login You…
Three members of the company's Board, Solveig Hellebust, Jean Pierre Bizzari and Thomas Ramdahl, has decided to step down from the Board with immediate effect. Following the decisions to discontinue the PARADIGME study for Betalutin, restructure the company and appoint Carnegie Investment Bank toAlready a subscriber Login You have read…
SAGA Diagnostics has announced the appointment of four people to significantly strengthen SAGA’s team. The new team members are Annina Hube, PhD MBA, as Director of Market Access, Rocco Crescenzo, MD, as Chief Medical Officer, and Maria Fe Paz, MD PhD MBA, and Florian Eckhardt, PhD MBA, as StraAlready a…
